Status:

Do Not Prescribe (DNP)

Decision Date:

September 2025

Comments

DNP: NICE TA1091: Tarlatamab for extensive-stage small-cell lung cancer after 2 or more treatments

Do Not Prescribe (DNP) Drug Classifications

• 6: Have NICE guidance that recommends they should not be used

search again